U.S., July 7 -- ClinicalTrials.gov registry received information related to the study (NCT07684391) titled 'Effect of Oral Astaxanthin Formula on Pulmonary Rehabilitation in Patients With COPD' on Feb. 13, 2024.

Brief Summary: The goal of this clinical trial is to investigate whether an astaxanthin-based dietary supplement combined with a pulmonary rehabilitation training program could improve exercise capacity in patients with COPD. The main questions it aims to answer are:

* whether an astaxanthin-based dietary supplement combined with a pulmonary rehabilitation training program could improve 6MWD in patients with COPD.

The drug administration group will receive:

* Two capsules of astaxanthin formula supplement daily for 8 weeks.

* P...